Prolyl hydroxylase domain inhibitors: a new era in the management of renal anemia

被引：5
|
作者：
Kurata, Yu [1 ]
Tanaka, Tetsuhiro [1 ]
Nangaku, Masaomi [1 ]
机构：
[1] Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Tokyo, Japan
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷
基金：
日本学术振兴会;
关键词：
HYPOXIA-INDUCIBLE FACTOR; KIDNEY; DISEASE; ANGIOGENESIS; ACTIVATION; EXPRESSION; INJURY; ALPHA;
D O I：
10.21037/atm.2019.09.118
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial Protection
    Requena-Ibanez, Juan Antonio
    Santos-Gallego, Carlos G.
    Rodriguez-Cordero, Anderly
    Zafar, M. Urooj
    Badimon, Juan Jose
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (06) : 1187 - 1196
  • [2] HIF prolyl hydroxylase inhibitors for anemia
    Muchnik, Eugene
    Kaplan, Joshua
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (05) : 645 - 656
  • [3] Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial Protection
    Juan Antonio Requena-Ibáñez
    Carlos G. Santos-Gallego
    Anderly Rodriguez-Cordero
    M. Urooj Zafar
    Juan José Badimon
    Cardiovascular Drugs and Therapy, 2022, 36 : 1187 - 1196
  • [4] Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease
    Sugahara, Mai
    Tanaka, Tetsuhiro
    Nangaku, Masaomi
    KIDNEY INTERNATIONAL, 2017, 92 (02)
  • [5] Prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease
    Cases, A.
    Vera, M.
    Ojeda, R.
    Gorriz, J. L.
    DRUGS OF THE FUTURE, 2018, 43 (01) : 23 - 33
  • [6] Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases
    Joharapurkar, Amit A.
    Pandya, Vrajesh B.
    Patel, Vishal J.
    Desai, Ranjit C.
    Jain, Mukul R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (16) : 6964 - 6982
  • [7] Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors
    Holt-Martyn, James P.
    Tumber, Anthony
    Rahman, Mohammed Z.
    Lippl, Kerstin
    Figg, William, Jr.
    McDonough, Michael A.
    Chowdhury, Rasheduzzaman
    Schofield, Christopher J.
    MEDCHEMCOMM, 2019, 10 (04) : 500 - 504
  • [8] Prolyl-hydroxylase inhibitors for the treatment of anemia in chronic kidney disease
    McMahon, Gearoid M.
    Singh, Ajay K.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2019, 28 (06) : 600 - 606
  • [9] Hypoxia-Inducible Factor-Prolyl Hydroxylase Domain Inhibitors to Treat Anemia in Chronic Kidney Disease
    Sakashita, Midori
    Tanaka, Tetsuhiro
    Nangaku, Masaomi
    CKD-ASSOCIATED COMPLICATIONS: PROGRESS IN THE LAST HALF CENTURY, 2019, 198 : 112 - 123
  • [10] Discovery of JTZ-951: A HIF Prolyl Hydroxylase Inhibitor for the Treatment of Renal Anemia
    Ogoshi, Yosuke
    Matsui, Takuya
    Mitani, Ikuo
    Yokota, Masahiro
    Terashita, Masakazu
    Motoda, Dai
    Ueyama, Kazuhito
    Hotta, Takahiro
    Ito, Takashi
    Hase, Yasunori
    Fukui, Kenji
    Deai, Katsuya
    Yoshiuchi, Hiromi
    Ito, Soichiro
    Abe, Hiroyuki
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (12): : 1320 - 1325
12345